ATE429484T1 - Verfahren zur bindung von acma-typ protein anker fusionen an mikroorganismen zellwandmaterialien - Google Patents

Verfahren zur bindung von acma-typ protein anker fusionen an mikroorganismen zellwandmaterialien

Info

Publication number
ATE429484T1
ATE429484T1 AT02741528T AT02741528T ATE429484T1 AT E429484 T1 ATE429484 T1 AT E429484T1 AT 02741528 T AT02741528 T AT 02741528T AT 02741528 T AT02741528 T AT 02741528T AT E429484 T1 ATE429484 T1 AT E429484T1
Authority
AT
Austria
Prior art keywords
cell
acma
binding
cell wall
type protein
Prior art date
Application number
AT02741528T
Other languages
English (en)
Inventor
Cornelis Leenhouts
Ranjan Ramasamy
Anton Steen
Jan Kok
Girbe Buist
Oscar Kuipers
Original Assignee
Applied Nanosystems Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Nanosystems Bv filed Critical Applied Nanosystems Bv
Application granted granted Critical
Publication of ATE429484T1 publication Critical patent/ATE429484T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02741528T 2001-06-11 2002-06-11 Verfahren zur bindung von acma-typ protein anker fusionen an mikroorganismen zellwandmaterialien ATE429484T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01202239 2001-06-11
PCT/NL2002/000383 WO2002101026A2 (en) 2001-06-11 2002-06-11 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms

Publications (1)

Publication Number Publication Date
ATE429484T1 true ATE429484T1 (de) 2009-05-15

Family

ID=8180461

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02741528T ATE429484T1 (de) 2001-06-11 2002-06-11 Verfahren zur bindung von acma-typ protein anker fusionen an mikroorganismen zellwandmaterialien

Country Status (10)

Country Link
US (4) US6896887B2 (de)
EP (1) EP1395648B1 (de)
CN (1) CN100513548C (de)
AT (1) ATE429484T1 (de)
AU (1) AU2002314626B2 (de)
CA (1) CA2450318C (de)
DE (1) DE60232071D1 (de)
DK (1) DK1395648T3 (de)
NZ (1) NZ530527A (de)
WO (1) WO2002101026A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024200D0 (en) * 2000-10-03 2000-11-15 Smithkline Beecham Sa Component vaccine
DE60232071D1 (de) * 2001-06-11 2009-06-04 Applied Nanosystems Bv Verfahren zur bindung von acma-typ protein anker fusionen an mikroorganismen zellwandmaterialien
US20040224343A1 (en) * 2003-05-06 2004-11-11 Biochain Inc. Methods and products to enhance interactions among molecules
EP1477802A1 (de) * 2003-05-16 2004-11-17 Erasmus Universiteit Rotterdam Verfahren zur Auswahl und zum Herstellung von Impfstoffkomponenten, und deren Verwendung in Impfstoffen
EP1746103A1 (de) * 2005-07-20 2007-01-24 Applied NanoSystems B.V. Bifunktionelle Protein-Anker
WO2008128189A1 (en) * 2007-04-13 2008-10-23 The Penn State Research Foundation Anti-cancer compositions and methods
EP2308506A1 (de) 2009-10-02 2011-04-13 Mucosis B.V. Intranasale Adjuvansimpfstoffformulierungen
WO2011044576A2 (en) * 2009-10-09 2011-04-14 Children's Medical Center Corporation Selectively disrupted whole-cell vaccine
PT2493498T (pt) * 2009-10-30 2017-05-24 Glaxosmithkline Biologicals Sa Purificação de sacáridos capsulares de staphylococcus aureus tipo 5 e tipo 8
WO2011060093A2 (en) * 2009-11-10 2011-05-19 National Jewish Health Compositions, methods and uses for stimulating immune responses
CN103403160A (zh) 2010-08-13 2013-11-20 G·克里斯蒂安森 修饰肽的展示
JP6069295B2 (ja) 2011-03-22 2017-02-01 ミュコシス ベー．フェー． 免疫組成物、免疫組成物の製造方法、疾患の治療剤または予防剤、組み替えポリペプチド、核酸配列、ベクターおよび宿主細胞
WO2013034687A1 (en) 2011-09-09 2013-03-14 Universität Bern Verwaltungsdirektion Avibacterium paragallinarum rtx toxin
CN103013897A (zh) * 2012-10-30 2013-04-03 东北农业大学 一种干酪乳杆菌菌影及其制备方法和应用
US9060975B2 (en) 2013-03-14 2015-06-23 Mucosis Bv Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions
WO2015105973A1 (en) * 2014-01-08 2015-07-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF
WO2016140702A1 (en) * 2015-03-03 2016-09-09 The United States Of America, As Represented By The Secretary, Department Of Health & Human Serivces Display platform from bacterial spore coat proteins
CN105784984B (zh) * 2016-03-01 2017-12-19 南京财经大学 革兰氏阳性菌菌影的制备方法及其应用
KR101825439B1 (ko) * 2016-04-15 2018-02-05 배재대학교 산학협력단 염산 처리에 의한 그람양성 박테리아 고스트의 제조 방법
CN107417773B (zh) * 2016-05-30 2020-09-08 国盛生化股份有限公司 黏合细胞壁之胜肽
CN105968213A (zh) * 2016-06-14 2016-09-28 长春百克生物科技股份公司 一种肺炎链球菌融合蛋白及其疫苗
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
US11844829B2 (en) 2016-12-28 2023-12-19 Zalvac Ab Microparticles from Streptococcus pneumoniae as vaccine antigens
CN107460173B (zh) * 2017-09-08 2020-09-22 江苏省农业科学院 一种纯化猪流行性腹泻病毒、猪繁殖与呼吸综合征病毒或禽流感病毒的方法
CA3080253A1 (en) 2017-10-25 2019-05-02 Allero Therapeutics Bv Treatment of immune diseases by administration of antigen-specific formulations
AU2021252164B2 (en) 2020-04-09 2026-07-02 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
US12194157B2 (en) 2020-04-09 2025-01-14 Finncure Oy Carrier for targeted delivery to a host
CN117343195A (zh) * 2022-06-27 2024-01-05 南京华狮新材料有限公司 一种固定化酶及其用于制备乙基己基甘油的用途及方法
EP4678183A1 (de) 2024-07-12 2026-01-14 Allero Therapeutics B.V. Behandlung von immunkrankheiten durch verabreichung von mrna-formulierungen

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2788987B2 (ja) 1988-08-31 1998-08-20 協同乳業株式会社 免疫賦活作用を有する粗糖蛋白質画分及びその製造法
DE3919644A1 (de) 1989-06-16 1990-12-20 Diagen Inst Molekularbio Mittel zur prophylaktischen und therapeutischen behandlung von viralen infektionen
DE4005874A1 (de) 1990-02-24 1991-11-07 Boehringer Mannheim Gmbh Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine
US5821088A (en) 1990-05-11 1998-10-13 Siga Pharmaceuticals, Inc. Use of gram-positive bacteria to express recombinant proteins
US5616686A (en) 1990-05-11 1997-04-01 The Rockefeller University Polypeptide of a hybrid surface protein by bacteria
DE4023721A1 (de) 1990-07-26 1992-01-30 Boehringer Mannheim Gmbh Verfahren zur herstellung von vakzinen und ihre verwendung
US6177083B1 (en) 1990-07-26 2001-01-23 Evax Technologies Gmbh Process for the production of vaccines and their use
IT1252160B (it) * 1991-12-03 1995-06-05 Giuseppe Fichera Composizioni farmaceutiche contenenti il peptidoglicano del lactobacillus casei
DK0673427T3 (da) 1992-07-08 2003-07-21 Unilever Nv Enzymatisk proces under anvendelse af enzymer immobiliseret på cellevæggen af en eukaryotisk mikrobiel celle ved fremstilling af et fusionsprotein
DE69433279T2 (de) 1993-02-10 2004-07-15 Unilever N.V. Isolierungsverfahren verwendend immobilisierte proteine mit spezifischen bindungskapazitäten
US5955258A (en) 1994-05-12 1999-09-21 Quest International B.V. Process for the lysis of a culture of lactic acid bacteria by means of a lysin, and uses of the resulting lysed culture
DE4422859C2 (de) 1994-06-30 2000-10-05 Laves Arzneimittel Gmbh Wäßrige Zellextrakte aus Mykobacterien
CA2201616A1 (en) 1994-10-07 1996-04-18 Vincent A. Fischetti Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria
EP1162271A3 (de) 1994-11-18 2003-01-15 Stichting Nederlands Instituut Voor Zuivelonderzoek Verfahren zur Kontrolle der Genexpression in Milchsäurebakterien
DE19603649A1 (de) 1996-02-01 1997-08-07 Werner Lubitz Rekombinante Expression von S-Layer-Proteinen
DE19633698A1 (de) 1996-08-21 1998-02-26 Lubitz Werner Prof Dr Neue Systeme zur Regulation der Genexpression
JP4049408B2 (ja) 1996-10-24 2008-02-20 株式会社ヤクルト本社 グラム陽性菌菌体表面へのタンパク質の固定化方法
WO1998025836A1 (en) 1996-12-11 1998-06-18 Lawson Mardon Wheaton Inc. Container closure with slide lock
ES2513043T3 (es) 1997-03-26 2014-10-24 Imperial Innovations Limited Proteína de fusión anticoagulante anclada a membrana de la célula
EP0916726A1 (de) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Befestigungs-Substanzen an Mikroorganismen
DE19800746A1 (de) 1998-01-12 1999-07-15 Muscholl Silberhorn Albrecht D Bakterielle Plasmidvektoren basierend auf alpha-Amylase mit breitem Wirtsspektrum und multiplen Anwendungen, unter besonderer Berücksichtigung Gram-positiver Bakterien
DE19903345A1 (de) 1999-01-28 2000-08-03 Werner Lubitz Kompartimentierung von rekombinanten Polypeptiden in Wirtszellen
DE19909770A1 (de) 1999-03-05 2000-09-07 Werner Lubitz Bakterienghosts als Träger- und Targetingvehikel
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
DE10003241A1 (de) 2000-01-26 2001-08-02 Werner Lubitz Verschließen von Bakterienghosts
US6827940B1 (en) * 2000-05-25 2004-12-07 Aidan Products, Llc Immune-stimulating bacterial cell wall extracts
JP2002017357A (ja) 2000-07-04 2002-01-22 Calpis Co Ltd アンカーペプチド、融合蛋白質、及び蛋白質の固定化方法
DE60232071D1 (de) * 2001-06-11 2009-06-04 Applied Nanosystems Bv Verfahren zur bindung von acma-typ protein anker fusionen an mikroorganismen zellwandmaterialien
EP1634948A1 (de) * 2004-09-10 2006-03-15 Basf Aktiengesellschaft Mittel und Verfahren zur Vorbeugung und/oder Behandlung von Karies
JP2008269669A (ja) * 2007-04-17 2008-11-06 Renesas Technology Corp 半導体装置及びデータ処理システム

Also Published As

Publication number Publication date
US20060115491A1 (en) 2006-06-01
DK1395648T3 (da) 2009-08-03
US20090239264A1 (en) 2009-09-24
US6896887B2 (en) 2005-05-24
EP1395648A2 (de) 2004-03-10
WO2002101026A8 (en) 2004-03-11
WO2002101026A2 (en) 2002-12-19
WO2002101026A3 (en) 2003-08-28
US7541039B2 (en) 2009-06-02
CN1541263A (zh) 2004-10-27
US7858357B2 (en) 2010-12-28
CN100513548C (zh) 2009-07-15
NZ530527A (en) 2006-06-30
EP1395648B1 (de) 2009-04-22
DE60232071D1 (de) 2009-06-04
US20030180816A1 (en) 2003-09-25
CA2450318C (en) 2011-08-02
US20030186851A1 (en) 2003-10-02
AU2002314626B2 (en) 2008-01-03
US7067639B2 (en) 2006-06-27
CA2450318A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
DE60232071D1 (de) Verfahren zur bindung von acma-typ protein anker fusionen an mikroorganismen zellwandmaterialien
SE9803838D0 (sv) A chromatography method and a column material useful in said method
WO2004069211A3 (en) Affinity proteins for controlled application of cosmetic substances
DE19980848D2 (de) Verfahren zur Detektion von Mikroorganismen in Produkten
EP1626730A4 (de) Verfahren, gerät und zusammensetzung zur behandlung von akne
DE59907067D1 (de) Polymer-Werkstoff und Herstellungsverfahren, sowie System und Verfahren zur Materialüberprüfung von Polymer-Werkstoffen und Bauteilen
EP1295590A3 (de) Zweikomponenten-Mittel mit zeitlichem pH-Gradienten und Verfahren zur Behandlung von Haaren
DE69907770D1 (de) Verfahren zur Herstellung von modifizierten PTFE
DE50113292D1 (de) Verfahren zur abreicherung von endotoxinen
ATE279702T1 (de) Verfahren und vorrichtung zur behandlung von organischem material
ATE278441T1 (de) Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind
ATE316193T1 (de) Verfahren zur behandlung von bohrlöchern
DE60019123D1 (de) Verfahren zur behandlung von petroleumsäuren
DE69807136D1 (de) Verfahren zur Identifizierung von Substanzen, die die Bindung von TL2 (TRAIL) an TR5 hemmen oder stimulieren.
DE60029429D1 (de) Verfahren und zusammensetzungen zur überwachung der modifikation von natürlichen bindungspartners
DE69629965D1 (de) Verfahren zur Extraktion von periplasmatischen Proteinen aus prokaryotischen Mikroorganismen in der Anwesenheit von Arginin
ATE303436T1 (de) Verfahren zur langzeitlagerung von dns-molekülen, und verpackung zur durchführung dieses verfahrens
ATE262353T1 (de) Verfahren zur entfernung von legionellen aus wässrigen strömen mittels elektropulsierung
DE60129547D1 (de) Verfahren zur kultivierung von mikroorganismen
DE502006008296D1 (de) Verfahren und formulierung zur extraktion von nukleinsäuren aus beliebigen komplexen ausgangsmaterialien
AU2002346403A8 (en) Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking
ATE483848T1 (de) Verfahren zur behandlung von cellulosischen formkörpern
DE69927593D1 (de) Verfahren zur abtrennung von hydroxymethylthiobuttersäure
DE69825612D1 (de) Verfahren zur biochemischen behandlung von tierischen fasern sowie dadurch hergestellte fasern und artikel
DE60113643D1 (de) Verfahren zur Bindung von Nukleinsäuren an einen Träger

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1395648

Country of ref document: EP